Elicera Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Elicera Therapeutics has a total shareholder equity of SEK16.4M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK30.2M and SEK13.8M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
Interest coverage ratio | n/a |
Cash | kr29.38m |
Equity | kr16.40m |
Total liabilities | kr13.78m |
Total assets | kr30.18m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ELIC's short term assets (SEK30.2M) exceed its short term liabilities (SEK13.8M).
Long Term Liabilities: ELIC's short term assets (SEK30.2M) exceed its long term liabilities (SEK7.0K).
Debt to Equity History and Analysis
Debt Level: ELIC is debt free.
Reducing Debt: ELIC has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ELIC has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ELIC has less than a year of cash runway if free cash flow continues to reduce at historical rates of 28.8% each year